Jefferson Health

Physician Profile

Danielle Duffy, MD

Jefferson University Physician

Academic Title: Assistant Professor

Specialties
Cardiology - Lipid Disorders (Not Accepting New Patients)
Cardiology - Women's Heart Health (Not Accepting New Patients)
Cardiology (Not Accepting New Patients)

Office Locations

Philadelphia
925 Chestnut Street
Mezzanine
Philadelphia PA 19107
Phone: (215) 955-5050
Fax: (215) 503-3976

Board Certifications

  • Internal Medicine
  • Cardiovascular Disease

Hospital Affiliation / Admitting Privileges

  • Thomas Jefferson University Hospital

Awards and Honors

American Heart Association Southeastern Pennsylvania Chapter ,201

Education

  • University of Pennsylvania School of Medicine, Medical School

Internship

  • Hospital of the University of Pennsylvania

Residency

  • Hospital of the University of Pennsylvania

Fellowship

  • Hospital of the University of Pennsylvania
  • Thomas Jefferson University Hospital

Recent Publications

Impact of the 2013 American College of Cardiology/American Heart Association cholesterol guidelines on the prescription of high-intensity statins in patients hospitalized for acute coronary syndrome or stroke

US physician practices for diagnosing familial hypercholesterolemia: data from the CASCADE-FH registry

Treatment gaps in adults with heterozygous familial hypercholesterolemia in the United States

Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical Practice

2013 ACC/AHA cholesterol treatment guideline: Paradigm shifts in managing atherosclerotic cardiovascular disease risk

Targeting Lipoprotein (a): an Evolving Therapeutic Landscape

Novel treatments for familial hypercholesterolemia: PharmacogenetiCs At Work

Novel treatments for familial hypercholesterolemia: Pharmacogenetics at work

PA32540 for the secondary prevention of cardiovascular disease in patients at risk for aspirin-associated gastric ulcers

Aspirin for cardioprotection and strategies to improve patient adherence

Pharmacokinetic interactions of the microsomal triglyceride transfer protein inhibitor, lomitapide, with drugs commonly used in the management of hypercholesterolemia

The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction

Potent and selective PPAR-α agonist LY518674 upregulates both apoA-I production and catabolism in human subjects with the metabolic syndrome

Update on strategies to increase hdl quantity and function

Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients

Endocannabinoid Antagonism: Blocking the Excess in the Treatment of High-Risk Abdominal Obesity

Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transport

High-density lipoprotein cholesterol therapies: The next frontier in lipid management

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

Drugs in development: Targeting high-density lipoprotein metabolism and reverse cholesterol transport